Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs.
Orditura M, Della Corte CM, Diana A, Ciaramella V, Franzese E, Famiglietti V, Panarese I, Franco R, Grimaldi A, Lombardi A, Caraglia M, Santoriello A, Procaccini E, Lieto E, Maiello E, De Vita F, Ciardiello F, Morgillo F. Orditura M, et al. Among authors: franco r. Breast. 2018 Oct;41:165-171. doi: 10.1016/j.breast.2018.08.002. Epub 2018 Aug 4. Breast. 2018. PMID: 30103105
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes.
Marra M, Salzano G, Leonetti C, Tassone P, Scarsella M, Zappavigna S, Calimeri T, Franco R, Liguori G, Cigliana G, Ascani R, La Rotonda MI, Abbruzzese A, Tagliaferri P, Caraglia M, De Rosa G. Marra M, et al. Among authors: franco r. Nanomedicine. 2011 Dec;7(6):955-64. doi: 10.1016/j.nano.2011.03.004. Epub 2011 Mar 29. Nanomedicine. 2011. PMID: 21453789
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Marra M, Salzano G, Leonetti C, Porru M, Franco R, Zappavigna S, Liguori G, Botti G, Chieffi P, Lamberti M, Vitale G, Abbruzzese A, La Rotonda MI, De Rosa G, Caraglia M. Marra M, et al. Among authors: franco r. Biotechnol Adv. 2012 Jan-Feb;30(1):302-9. doi: 10.1016/j.biotechadv.2011.06.018. Epub 2011 Jun 30. Biotechnol Adv. 2012. PMID: 21741464
Deregulation of HOX B13 expression in urinary bladder cancer progression.
Marra L, Cantile M, Scognamiglio G, Perdonà S, La Mantia E, Cerrone M, Gigantino V, Cillo C, Caraglia M, Pignata S, Facchini G, Botti G, Chieffi S, Chieffi P, Franco R. Marra L, et al. Among authors: franco r. Curr Med Chem. 2013 Feb 1;20(6):833-9. Curr Med Chem. 2013. PMID: 23276138
EGFR mutational status in penile cancer.
Di Lorenzo G, Buonerba C, Gaudioso G, Gigantino V, Quarto G, De Domenico R, Caraglia M, Di Trolio R, Ascierto PA, De Placido S, Perdonà S, Franco R. Di Lorenzo G, et al. Among authors: franco r. Expert Opin Ther Targets. 2013 May;17(5):501-5. doi: 10.1517/14728222.2013.783571. Epub 2013 Mar 22. Expert Opin Ther Targets. 2013. PMID: 23517177
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?
Franco R, Rocco G, Marino FZ, Pirozzi G, Normanno N, Morabito A, Sperlongano P, Stiuso P, Luce A, Botti G, Caraglia M. Franco R, et al. Expert Rev Anticancer Ther. 2013 Apr;13(4):407-20. doi: 10.1586/era.13.18. Expert Rev Anticancer Ther. 2013. PMID: 23560836 Review.
Predictive biomarkers along gastric cancer pathogenetic pathways.
Panarese I, De Vita F, Ronchi A, Romano M, Alfano R, Di Martino N, Zito Marino F, Ferraraccio F, Franco R. Panarese I, et al. Among authors: franco r. Expert Rev Anticancer Ther. 2017 May;17(5):417-425. doi: 10.1080/14737140.2017.1301207. Epub 2017 Mar 15. Expert Rev Anticancer Ther. 2017. PMID: 28277834 Review.
1,973 results